CELON PHARMA Spólka Akcyjna S.A. – Trademark Portfolio

Entity Type: 99

CELON PHARMA Spólka Akcyjna S.A. holds 2 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 5 (Pharmaceuticals) — 2 filings in this category. The portfolio also extends into Class 10 (Medical Apparatus) across 2 Nice Classification classes. Currently, 1 trademark is registered. Notable registered marks include REDUZEK. The owner is based in Lomianki.

Kielpin, Ogrodowa 2a

Lomianki PL-05-092 , PL

2 Total Trademarks

Add to watchlist:

No watchlists yet
Loading...
By Date
By Name
Filter by Class:

REDUZEK
REDUZEK
Registered 2024

Trademark Classifications

CELON PHARMA Spólka Akcyjna S.A.'s trademark portfolio spans 2 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.

5
Pharmaceuticals (2 filings)

Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes

10
Medical Apparatus (1 filing)

Surgical, medical, dental and veterinary apparatus and instruments

Frequently Asked Questions

How many trademarks does CELON PHARMA Spólka Akcyjna S.A. have?

CELON PHARMA Spólka Akcyjna S.A. has 2 U.S. trademarks filed with the USPTO. Of these, 1 registered, 1 abandoned.

What trademark classes does CELON PHARMA Spólka Akcyjna S.A. file in?

CELON PHARMA Spólka Akcyjna S.A. files trademarks across 2 Nice Classification classes. The most active classes are Class 5 (Pharmaceuticals), Class 10 (Medical Apparatus). Class 5 covers pharmaceutical and veterinary preparations; sanitary preparations for medical purposes.

What are CELON PHARMA Spólka Akcyjna S.A.'s most well-known trademarks?

CELON PHARMA Spólka Akcyjna S.A.'s registered trademark portfolio includes well-known marks such as REDUZEK. These are among 1 currently registered trademark in the portfolio.

What is CELON PHARMA Spólka Akcyjna S.A.'s trademark registration success rate?

CELON PHARMA Spólka Akcyjna S.A. has a 50% trademark registration rate, with 1 out of 2 resolved applications resulting in successful registration. Currently, 0 applications are pending review.